| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |